Pelizaeus-Merzbacher disease
Oct. 31, 2024
Erika Fullwood Augustine MD MS
Associate Chief Science Officer
Kennedy Krieger Institute
Associate Professor of Neurology
Johns Hopkins University
Baltimore, Maryland
Adjunct Associate Professor of Neurology and Pediatrics
University of Rochester Medical Center
Rochester, New York
Editorial Board Member since 2021: Neurogenetic Disorders
Clinical Interests: Neurology with Special Qualifications in Child Neurology
Contributor Disclosures
Dr. Augustine of Kennedy Krieger Institute, Johns Hopkins University, and University of Rochester Medical Center received a clinical trial agreement as Central Rater from Neurogene Inc, and an honorarium as a member of the Data Safety and Monitory Board for PTC Therapeutics.